-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Nabriva Therapeutics plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2015 to Q1 2023.
- Nabriva Therapeutics plc Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2023 was -$4.85M, a 321% decline year-over-year.
- Nabriva Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.85M, a 97.2% decline from 2021.
- Nabriva Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $66.4M, a 146% increase from 2020.
- Nabriva Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2020 was $26.9M, a 52% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)